Relationship between clinicopathological features and HIF-2α in gastric adenocarcinoma

Genetics and Molecular Research

Volumn 14, Issue 1, 2015, Pages 1404-1413

  Li, N ^a   Wang, H X ^a   Qin, C ^a   Wang, X H ^a   Han, F Y ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathological characteristics; Gastric cancer; Hypoxia inducible factor 2 ; Prognosis

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; MMP9 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TUMOR INVASION; TUMOR VOLUME; ADENOCARCINOMA; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HOMEOSTASIS; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930475149     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.February.13.19     Document Type: Article

References (21)

1. Bertout JA, Patel SA, Fryer BH, Durham AC, et al. (2009). Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. Cancer Res. 69: 3213-3220.
2. Bohensky J, Terkhorn SP, Freeman TA, Adams CS, et al. (2009). Regulation of autophagy in cartilage: HIF-2 suppresses chondrocyte autophagy. Arthritis Rheum. 60: 1406-1415.
3. Burrows N, Babur M, Resch J, Williams KJ, et al. (2011). Hypoxia-inducible factor in thyroid carcinoma. J. Thyroid Res.2011: 762905.
4. Choi YK, Kim CK, Lee H, Jeoung D, et al. (2010). Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J. Biol. Chem.285: 32116-32125.
5. Copple BL, Bai S and Moon JO (2010). Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic Kupffer cells. Hepatol. Res.40: 530-539.
6. Jiang Y, Zhang W, Kondo K, Klco JM, et al. (2003). Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol. Cancer Res. 1: 453-462.
7. Leonard MO, Howell K, Madden SF, Costello CM, et al. (2008). Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung. Am. J. Respir. Crit. Care Med. 178: 977-983.
8. Liu W, Xin H, Eckert DT, Brown JA, et al. (2011). Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor. Oncogene30: 21-31.
9. Majmundar AJ, Wong WJ and Simon MC (2010). Hypoxia inducible factors and the response to hypoxic stress. Mol. Cell. 40: 294-309.
10. Mardilovich K and Shaw LM (2009). Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion. Cancer Res. 69: 8894-8901.
11. Mazumdar J, Hickey MM, Pant DK, Durham AC, et al. (2010). HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc. Natl. Acad. Sci. U. S. A. 107: 14182-14187.
12. Meade ES, Ma YY and Guller S (2007). Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line. Placenta28: 1012-1019.
13. Milovanova TN, Bhopale VM, Sorokina EM, Moore JS, et al. (2009). Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J. Appl. Physiol. 106: 711-728.
14. Mole DR, Blancher C, Copley RR, Pollard PJ, et al. (2009). Genome-wide association of hypoxia-inducible factor (HIF)- 1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts. J. Biol. Chem. 284: 16767- 16775.
15. Rankin EB and Giaccia AJ (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15: 678-685.
16. Rankin EB, Beju MP, Liu Q, Unger TL, et al. (2007). Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest.117: 1068-1077.
17. Rankin EB, Rha J, Unger TL, Wu CH, et al. (2008). Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene27: 5354-5358.
18. Rankin EB, Rha J, Selak MA, Unger TL, et al. (2009). Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol. Cell Biol.29: 4527-4538.
19. Taylor CT (2008). Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation. J. Physiol.586: 4055-4059.
20. Trisciuogglio D, Gabellini C, Desidrei M, Ziparo E, et al. (2010). Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90. PLoS One5: e11772.
21. Zhu P, Ning Y, Yao L, Chen M, et al. (2010). The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia. J. Exp. Clin. Cancer Res. 29: 124.